Atrás
Rango del Día
$72.69
$74.77
Rango de 52 Semanas
$60.56
$89.29
Volumen
1,271,414
Promedio 50D / 200D
$77.69
/
$72.09
Cierre Anterior
$72.29
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 22.0 | 0.4 |
| P/B | 2.7 | 2.9 |
| ROE % | 12.0 | 3.7 |
| Net Margin % | 3.0 | 3.8 |
| Rev Growth 5Y % | 1.5 | 10.0 |
| D/E | 1.1 | 0.2 |
Puntos Clave
Revenue grew 1.54% annually over 5 years — modest growth
ROE of 11.99% — decent returns on equity
Generating 573.00M in free cash flow
Cash machine — converts 143.97% of earnings into free cash flow
Capital efficient — spends only 1.05% of revenue on capex
Crecimiento
Revenue Growth (5Y)
1.54%
Revenue (1Y)4.03%
Earnings (1Y)2.05%
FCF Growth (3Y)27.41%
Calidad
Return on Equity
11.99%
ROIC8.20%
Net Margin3.02%
Op. Margin5.75%
Seguridad
Debt / Equity
1.14
Current Ratio1.38
Interest Coverage5.05
Valoración
P/E Ratio
22.02
P/B Ratio2.70
EV/EBITDA16.22
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.03% | Revenue Growth (3Y) | 3.37% |
| Earnings Growth (1Y) | 2.05% | Earnings Growth (3Y) | -2.19% |
| Revenue Growth (5Y) | 1.54% | Earnings Growth (5Y) | -10.63% |
| Profitability | |||
| Revenue (TTM) | 13.18B | Net Income (TTM) | 398.00M |
| ROE | 11.99% | ROA | 3.55% |
| Gross Margin | 29.14% | Operating Margin | 5.75% |
| Net Margin | 3.02% | Free Cash Flow (TTM) | 573.00M |
| ROIC | 8.20% | FCF Growth (3Y) | 27.41% |
| Safety | |||
| Debt / Equity | 1.14 | Current Ratio | 1.38 |
| Interest Coverage | 5.05 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 22.02 | P/B Ratio | 2.70 |
| P/S Ratio | 0.66 | PEG Ratio | 3.22 |
| EV/EBITDA | 16.22 | Dividend Yield | 0.00% |
| Market Cap | 8.77B | Enterprise Value | 12.30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.18B | 12.67B | 12.34B | 12.65B | 12.40B |
| Net Income | 398.00M | 390.00M | 416.00M | 538.00M | 623.91M |
| EPS (Diluted) | 3.27 | 3.05 | 3.16 | 3.91 | 4.45 |
| Gross Profit | 3.84B | 3.77B | 3.65B | 3.65B | 3.67B |
| Operating Income | 758.00M | 729.00M | 714.00M | 938.00M | 854.81M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11.22B | 10.22B | 10.57B | 8.61B | 8.48B |
| Total Liabilities | 6.42B | 5.38B | 5.42B | 3.94B | 3.81B |
| Shareholders' Equity | 3.25B | 3.39B | 3.66B | 3.45B | 3.43B |
| Total Debt | 3.69B | 2.87B | 2.74B | 1.50B | 1.22B |
| Cash & Equivalents | 156.00M | 122.00M | 171.00M | 117.00M | 118.00M |
| Current Assets | 4.46B | 3.98B | 4.49B | 3.99B | 3.84B |
| Current Liabilities | 3.23B | 2.80B | 2.68B | 2.22B | 2.31B |